Journal of Biological Chemistry · 1998 · 91 citations · 21 references
MedicineCardiologyGeneticsCardiovascular GeneticsElectrophysiologyGene ExpressionCardiac Ion ChannelsCardiac PhysiologyChannelopathiesIon Channel DisordersIon Channel RegulationVentricular ElectrophysiologyCardiac Ion Channel RegulationCardiac RepolarizationChannelopathy GeneticsElectrophysiological PhenotypingInherited Cardiac ChannelopathiesLong Qt Syndrome ElectrophysiologyPatch-clamp Data AnalysisVentricular Repolarization
Mutations in the KvLQT1 gene are the cause of the long QT syndrome 1. KvLQT1 gene product is associated with the regulator protein IsK to produce a component of the delayed rectifier K+ current in cardiac myocytes. We identified an N-terminal truncated isoform of the KvLQT1gene product, referred to as isoform 2. In RNase protection assays, isoform 2 represented 28.1 ± 0.6% of the total KvLQT1 expression in the human adult ventricle. COS-7 cells injected intranuclearly with KvLQT1 isoform 1 cDNA exhibited a fast-activating K+ current, whereas those injected with a KvLQT1 isoform 1 plus IsK cDNA showed a slow-activating K+ current. Cells injected with KvLQT1 isoform 2 plasmid showed no detectable K+ current. Those injected with a 1/1 isoform 2/isoform 1 ratio showed no detectable K+ current. Those injected with 1/5 and 2/5 ratios showed a K+ current with markedly reduced amplitude. Coexpression of the IsK regulator consistently reduced the dominant negative effects of isoform 2. Our results indicate that KvLQT1 isoform 2 exerts a pronounced negative dominance on isoform 1 channels and that the cardiac KvLQT1 K+ channel complex is composed of at least three different proteins as follows: isoform 1, isoform 2, and IsK. Mutations in the KvLQT1 gene are the cause of the long QT syndrome 1. KvLQT1 gene product is associated with the regulator protein IsK to produce a component of the delayed rectifier K+ current in cardiac myocytes. We identified an N-terminal truncated isoform of the KvLQT1gene product, referred to as isoform 2. In RNase protection assays, isoform 2 represented 28.1 ± 0.6% of the total KvLQT1 expression in the human adult ventricle. COS-7 cells injected intranuclearly with KvLQT1 isoform 1 cDNA exhibited a fast-activating K+ current, whereas those injected with a KvLQT1 isoform 1 plus IsK cDNA showed a slow-activating K+ current. Cells injected with KvLQT1 isoform 2 plasmid showed no detectable K+ current. Those injected with a 1/1 isoform 2/isoform 1 ratio showed no detectable K+ current. Those injected with 1/5 and 2/5 ratios showed a K+ current with markedly reduced amplitude. Coexpression of the IsK regulator consistently reduced the dominant negative effects of isoform 2. Our results indicate that KvLQT1 isoform 2 exerts a pronounced negative dominance on isoform 1 channels and that the cardiac KvLQT1 K+ channel complex is composed of at least three different proteins as follows: isoform 1, isoform 2, and IsK. Mutations in the KvLQT1 gene are the most frequent cause of the congenital long QT syndrome, a familial disorder characterized by prolonged cardiac repolarization, syncope, and a high incidence of sudden death (1Wang Q. Curran M.E. Splawski I. Burn T.C. Millholland J.M. VanRaay T.J. Shen J. Timothy K.W. Vincent G.M. De Jager T. Schwartz P.J. Towbin J.A. Moss A.J. Atkinson D.L. Landes G.M. Connors T.D. Keating M.T. Nat. Genet. 1996; 12: 17-23Crossref PubMed Scopus (1504) Google Scholar). KvLQT1 is also responsible for the Jervell and Lange-Nielsen cardioauditory syndrome in which prolonged cardiac repolarization is associated with bilateral congenital deafness (2Neyroud N. Tesson F. Denjoy I. Leibovici M. Donger C. Barhanin J. Fauré S. Gary F. Coumel P. Petit C. Schwartz K. Guicheney P. Nat. Genet. 1997; 15: 186-189Crossref PubMed Scopus (752) Google Scholar). In a recent study, the KvLQT1 gene was found to encompass chromosomal rearrangements associated with the Beckwith-Wiedemann syndrome which causes prenatal overgrowth and cancer (3Lee M.P. Hu R.J. Johnson L.A. Feinberg A.P. Nat. Genet. 1997; 15: 181-185Crossref PubMed Scopus (272) Google Scholar). Thus, the same gene at locus 11p15.5 could be implicated in at least three distinct genetic disease entities. The KvLQT1 gene product is a six-transmembrane domain protein which, in association with a membranous regulator termed IsK (previously known as minK), produces a K+ current with physiological characteristics similar to those of the major component of the delayed rectifier sustained K+ current in cardiac myocytes (4Barhanin J. Lesage F. Guillemare E. Fink M. Lazdunski M. Romey G. Nature. 1996; 384: 78-80Crossref PubMed Scopus (1401) Google Scholar, 5Sanguinetti M.C. Curran M.E. Spector P.S. Zou A. Shen J. Atkinson D. Keating M.T. Nature. 1996; 384: 80-83Crossref PubMed Scopus (1524) Google Scholar). KvLQT1 expression is not limited to the heart muscle but can also be observed in human pancreas, lung, kidney, inner ear, and placenta (4Barhanin J. Lesage F. Guillemare E. Fink M. Lazdunski M. Romey G. Nature. 1996; 384: 78-80Crossref PubMed Scopus (1401) Google Scholar, 5Sanguinetti M.C. Curran M.E. Spector P.S. Zou A. Shen J. Atkinson D. Keating M.T. Nature. 1996; 384: 80-83Crossref PubMed Scopus (1524) Google Scholar, 6Chouabe C. Neyroud N. Guicheney P. Lazdunski M. Romey G. Barhanin J. EMBO J. 1997; 17: 5472-5479Crossref Scopus (240) Google Scholar). In autosomal dominant long QT syndrome 1, mutations in KvLQT1 supposedly decrease the amount of K+ current available for repolarization, thereby prolonging the cardiac action potential and inducing arrhythmias. In the recessively inherited Jervell and Lange-Nielsen syndrome, bi-allelic mutations in KvLQT1 (2Neyroud N. Tesson F. Denjoy I. Leibovici M. Donger C. Barhanin J. Fauré S. Gary F. Coumel P. Petit C. Schwartz K. Guicheney P. Nat. Genet. 1997; 15: 186-189Crossref PubMed Scopus (752) Google Scholar) not only alter cardiac electrophysiology but also inner ear endolymph homeostasis, leading to congenital deafness. In the present work, we have cloned an N-terminal truncated isoform of the KvLQT1 gene product corresponding to KvLQT1 isoform 2 simultaneously identified by Lee et al. (3Lee M.P. Hu R.J. Johnson L.A. Feinberg A.P. Nat. Genet. 1997; 15: 181-185Crossref PubMed Scopus (272) Google Scholar) and Yang et al. (7Yang W.P. Levesque P.C. Little W.A. Lee Conder M. Shalaby F.Y. Blanar M.A. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 4017-4021Crossref PubMed Scopus (183) Google Scholar). It was determined that KvLQT1 isoform 2, which is constitutively expressed in adult heart muscle, is a strong dominant negative of KvLQT1 isoform 1. Our results demonstrate that the cardiac K+ channel responsible for the long QT syndrome 1 is a complex protein assembly composed of isoform 1 (the channel pore), isoform 2 (a dominant negative), and IsK (the channel regulator). These findings could have important physiopathological implications. To obtain the 5′ sequence of KvLQT1, a rapid amplification of cDNA ends (RACE) 1The abbreviations used are: RACE, rapid amplification of cDNA ends; bp, base pair(s); RT-PCR, reverse transcriptase-polymerase chain reactions; HA, hemagglutinin; PBS, phosphate-buffered saline. experiment was performed using a Marathon cDNA Amplification kit and Marathon ready cDNA from human adult heart (CLONTECH). Two nested primers (LQTN1, 5′ GAT GTA CAG GGT GGT TAT CAG C 3′; and LQTN2, 5′ TGA GGT CGA TGA TGG AAA TGG G 3′) were derived from the previously published partial KvLQT1 sequence (1Wang Q. Curran M.E. Splawski I. Burn T.C. Millholland J.M. VanRaay T.J. Shen J. Timothy K.W. Vincent G.M. De Jager T. Schwartz P.J. Towbin J.A. Moss A.J. Atkinson D.L. Landes G.M. Connors T.D. Keating M.T. Nat. Genet. 1996; 12: 17-23Crossref PubMed Scopus (1504) Google Scholar), and RACE was performed according to the manufacturer's protocol. The fragment of 320 bp obtained was cloned in pUC 18 using the Sure Clone Ligation kit (Pharmacia Biotech Inc.). Sequencing reactions were subsequently performed on two independent clones using the dideoxy terminator cycle sequencing kit (Applied Biosystems). Sequencing reaction products were analyzed on 4.0% polyacrylamide gels using an ABI-377 automated DNA sequencer (Applied Biosystems). The sequence of both clones was identical, revealing a start codon 6 bp upstream from the previously published sequence (1Wang Q. Curran M.E. Splawski I. Burn T.C. Millholland J.M. VanRaay T.J. Shen J. Timothy K.W. Vincent G.M. De Jager T. Schwartz P.J. Towbin J.A. Moss A.J. Atkinson D.L. Landes G.M. Connors T.D. Keating M.T. Nat. Genet. 1996; 12: 17-23Crossref PubMed Scopus (1504) Google Scholar). Human heart RNA was prepared using left or right ventricular tissues from the explanted heart of a patient with cystic fibrosis. Right atrial appendage biopsies were also obtained during open heart surgery from six patients with coronary heart disease. Tissue samples were quick-frozen in liquid nitrogen, and total RNA was then isolated separately from each sample using the classical guanidinium isothiocyanate method (8Chomczynski P. Sacchi N. Anal. Biochem. 1987; 162: 156-159Crossref PubMed Scopus (63231) Google Scholar). RNA samples were quantified by spectrophotometric analysis. The lack of degradation of RNA samples was monitored by the observation of appropriate 28 S to 18 S ribosomal RNA ratios as determined by ethidium bromide staining of the agarose gel. Reverse transcriptase-polymerase chain reactions (RT-PCR) were performed on total RNA. cDNA was synthesized from approximately 1 μg of RNA. RT-PCR reactions contained 5 mmMgCl2, 1× PCR Buffer II, 1 mm dNTP, 1 unit/μl RNase inhibitor, 2.5 units/μl murine leukemia virus reverse transcriptase (Perkin-Elmer), and 0.75 μm primers in a final volume of 20 μl. Controls without reverse transcriptase were performed to check that amplification did not proceed from residual genomic DNA. cDNA was used for PCR reactions with 2 mmMgCl2, 1× PCR Buffer II, 2.5 units/100 μl AmpliTaq DNA polymerase (Perkin-Elmer), and 0.5 μm primers (Genosys) in a final volume of 100 μl. PCR reactions were performed as follows with a Peltier Thermal Cycler (PTC-200; MJ Research). cDNA was heated to 95 °C for 105 s and then amplified by 40 cycles (95 °C for 15 s and 60 °C for 30 s) before primer extension at 72 °C for 7 min. Ten microliters of each PCR product were analyzed by electrophoresis on a 2% agarose NA (Pharmacia) gel, followed by ethidium bromide staining. Sequences of the sense (F1) and antisense (R) oligonucleotide primers for human KvLQT1 isoform 1 are shown in Fig. 1. The sense primer (F2) used for specific detection of human KvLQT1 isoform 2 is also shown in Fig. 1. Sense 5′-TCCTGTCTAACACCACAGCG-3′ and antisense 5′-TTCAACGACATAGCACGACC-3′ were used for IsK. Sense 5′-GGCATCGTGATGGACTCCG-3′ and antisense 5′-GCTGGAAGGTGGACAGCGA-3′ were used for human β-actin. The expected fragment lengths calculated from cDNA sequences were 274, 245, 326, and bp for KvLQT1 isoform 1, isoform 2, and different were used as for RNase protection The was a human KvLQT1 isoform 1 cDNA corresponding to the 5′ upstream and from the start codon cDNA specific for isoform 1, which in an RNase protection a isoform fragment and a fragment that 1 The was from the expression using primers the and of a The was a human KvLQT1 isoform 2 cDNA corresponding to the 5′ upstream and the 320 from the start cDNA specific for isoform 2, which in an RNase protection a isoform fragment and a 2 was from the expression the and of a The was a human cDNA corresponding to the IsK sequence RNA were using and on KvLQT1 isoform 1, KvLQT1 isoform 2, and IsK in the of RNase protection were as previously J. J. 1997; Google Scholar) using the each 15 μg of total RNA were to 105 of the RNA The RNA was RNase on a gel. Sense KvLQT1 isoform 1 RNA was also and was on the same for as a as as RNA were using RNA with the isoform 1 and isoform 2 were for at °C on with an of RNase protection were to using the The ratios of KvLQT1 isoform 1 and KvLQT1 isoform 2 were determined from specific were with the same The COS-7 was obtained from the Cells on were with at 1 Our to cells using the in S. D. G. I. D. J. Google Scholar). were at a final of in a composed with Human cardiac KvLQT1 isoform 1 KvLQT1 isoform 2, as as IsK were the expression the of a The KvLQT1 isoform 2 was derived from the isoform 1 plasmid using polymerase chain reaction and protein plasmid (a from was used as an plasmid to that cells were injected with a 15 plasmid were as previously S. D. G. I. D. J. Google Scholar). cells was on the of an and with the 1, 1, to with with a were to a The contained 2, 2 2, with whereas the used to K+ contained 7 with and were performed an and rapid of the different at are as the ± The of the observed effects was by of the The sequence the PubMed Scopus Google Scholar) was in with the KvLQT1 isoform 1 sequence to the of the and isoform 1 plasmid was with and and the fragment was pUC and then with and sense oligonucleotide the sequence was with reverse oligonucleotide and and The product was with and and the isoform 1 To the KvLQT1 isoform 2 a PCR reaction was performed using the KvLQT1 isoform 1 plasmid as a KvLQT1 were by expression of the was by of cells not COS-7 cells in were with using as a cells were with phosphate-buffered with μl of mm 100 mm 2% and The samples were in a for and the chromosomal DNA was by for 2 min. were at for at and the was used for was determined using the as a were by electrophoresis on polyacrylamide gels using the The proteins were to an was in a mm and at 100 for of the were with with and for 1 at The was in and 20 and with the for 1 at the were 5 with and for 1 at in a of a The were then for 30 with and by the were used to protein in the COS-7 cells on were three with with 1 mm and 0.5 mm and with the in PBS, for 1 at Cells were three and for 30 at with a at in PBS, The cells were subsequently and then using a with The were and then in a to was observed using a performed on human heart cDNA identified a to a truncated KvLQT1 protein an N-terminal The N-terminal sequence was only 2 and the previously published partial sequence (1Wang Q. Curran M.E. Splawski I. Burn T.C. Millholland J.M. VanRaay T.J. Shen J. Timothy K.W. Vincent G.M. De Jager T. Schwartz P.J. Towbin J.A. Moss A.J. Atkinson D.L. Landes G.M. Connors T.D. Keating M.T. Nat. Genet. 1996; 12: 17-23Crossref PubMed Scopus (1504) Google Scholar) and the cardiac KvLQT1 isoform 1 C. Neyroud N. Guicheney P. Lazdunski M. Romey G. Barhanin J. EMBO J. 1997; 17: 5472-5479Crossref Scopus (240) Google Scholar). sequence identified from the start codon the KvLQT1 sequence published by Lee et al. (3Lee M.P. Hu R.J. Johnson L.A. Feinberg A.P. Nat. Genet. 1997; 15: 181-185Crossref PubMed Scopus (272) Google Scholar). RT-PCR primers specific for each isoform were both and N-terminal truncated KvLQT1 isoform were in human ventricular tissues from an explanted heart 2 was also in six right atrial during open heart cardiac surgery was quantified in adult human cardiac muscle using an RNase protection The used for isoform 2 detection bp and a of isoform and sequences as as a sequence to 1 and 2. Thus, with isoform 2 two RNA were as follows: a sequence corresponding to isoform 2 and a sequence corresponding to 2 isoform 1, the RNase protection a which a fragment of isoform 5′ sequence and a to isoform 1 and 2 sequences the two RNA were a sequence corresponding to isoform 1 and a sequence corresponding to 1 of the expression of the different without the for an was used to isoform 1 and isoform 2 from cardiac that isoform 1 and isoform 2 represented ± and 28.1 ± of the total KvLQT1 expression in the and ± and ± in the ± expression of isoform 2 in the was in the of for KvLQT1 isoform 1 and isoform 2 in human and RNase protection demonstrate the of the a fragment ventricular or RNA was with the IsK and cardiac RNA was with the isoform 1 and RNA was with the isoform 2 We KvLQT1 isoform 2 is to the To COS-7 cells were with KvLQT1 isoform 1 or KvLQT1 isoform 2. In the was the of the channel protein that of the could be performed in that specific as at the of cells with isoform 1 and isoform 2 but not at the of cells with an performed in COS-7 cells with that KvLQT1 isoform 1 and KvLQT1 isoform 2 proteins at the and by as shown in Fig. two different for each isoform were on the We that the to the of the whereas the to the (1Wang Q. Curran M.E. Splawski I. Burn T.C. Millholland J.M. VanRaay T.J. Shen J. Timothy K.W. Vincent G.M. De Jager T. Schwartz P.J. Towbin J.A. Moss A.J. Atkinson D.L. Landes G.M. Connors T.D. Keating M.T. Nat. Genet. 1996; 12: 17-23Crossref PubMed Scopus (1504) Google Scholar). expression were using In we used the plasmid to of the expression of the different COS-7 cells intranuclearly injected with KvLQT1 isoform 2 exhibited no detectable K+ current in the or of the IsK To a to isoform 2 isoform 2 was with isoform 1 in the or of IsK. In a protein plasmid was used as an plasmid to that the total plasmid injected was 15 Cells injected with 5 KvLQT1 isoform 1 exhibited a K+ current characterized by and 5 and Cells with 5 isoform 1 plus 5 isoform 2 5 no detectable K+ current Cells with 5 isoform 1 plus 1 isoform 2 exhibited a K+ current with similar but with markedly reduced and Fig. 5 C that the for the isoform K+ current was not by the of isoform 2. In six different during which current were the of the KvLQT1 isoform 1 current was not by the of isoform 2 of was also performed in the of IsK Cells with 5 isoform 1 and 5 IsK 5 exhibited a K+ current with a similar but cells injected with isoform 1 of isoform 2 with isoform 1 consistently reduced the K+ current in the of IsK and shown in Fig. 6 the of isoform 2 did not the but the by to a in the of isoform 2 did not alter the and of the isoform K+ current in Fig. isoform 2 reduced current In the of 1, 2, and 5 isoform 2 but without the current by 5 isoform 1 was reduced to and of In the of 5 the same of isoform 2 reduced current to and of Thus, the current to isoform 1 expression was to the negative dominance of isoform 2 in the in the of IsK. Fig. 7 also that the dominant negative effects by 1 isoform 2 were by the IsK plasmid in the injected from 5 to KvLQT1 K+ in COS-7 cells with 5 The same abbreviations and as in Fig. 5 are obtained in a injected with isoform 2 plasmid in a injected with 5 isoform 1 plasmid and in a with 5 isoform 1 plus 1 isoform 2 1 for 2 and for the 1 and 1 2. 5 current in cells injected with isoform 1 isoform 1 plus isoform 2 and with isoform 2 cells as in A. KvLQT1 in the and of isoform 2. the potential for and for the K+ current to KvLQT1 isoform 1 expression and in the or of KvLQT1 isoform 2 without and with ± ± ± ± ± ± ± ± ± ± ± ± in a of KvLQT1 isoform 2 on the current to isoform 1 the left obtained in the of and the right obtained in the of IsK. The of the current to isoform 1 expression was determined for isoform 2 cDNA ratios in the injected in the for isoform 1 isoform 2 and IsK are on the Cells were also with a plasmid the total plasmid was 15 and is with cells injected with KvLQT1 isoform 1 is in indicate Our results demonstrate that an N-terminal truncated isoform of the KvLQT1 gene product is constitutively expressed in adult human heart and that truncated isoform is a strong dominant negative of KvLQT1 isoform 1 K+ The isoform 2 sequence to that identified by Yang et al. (7Yang W.P. Levesque P.C. Little W.A. Lee Conder M. Shalaby F.Y. Blanar M.A. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 4017-4021Crossref PubMed Scopus (183) Google Scholar) and is referred to as In expression was in the heart but not in (7Yang W.P. Levesque P.C. Little W.A. Lee Conder M. Shalaby F.Y. Blanar M.A. Proc. Natl. Acad. Sci. U. S. A. 1997; 94: 4017-4021Crossref PubMed Scopus (183) Google Scholar). the genomic (3Lee M.P. Hu R.J. Johnson L.A. Feinberg A.P. Nat. Genet. 1997; 15: 181-185Crossref PubMed Scopus (272) Google Scholar), isoform 2 1, and 2 but of the KvLQT1 and (3Lee M.P. Hu R.J. Johnson L.A. Feinberg A.P. Nat. Genet. 1997; 15: 181-185Crossref PubMed Scopus (272) Google Scholar) demonstrate that 1 and 2 are The KvLQT1 gene a of at least and a of (3Lee M.P. Hu R.J. Johnson L.A. Feinberg A.P. Nat. Genet. 1997; 15: 181-185Crossref PubMed Scopus (272) Google Scholar). the KvLQT1 not can be that isoform 1 and isoform 2 the same a different as is the for 2, for which of and Nature. PubMed Scopus Google Scholar). The N-terminal of KvLQT1 to be for the but not for the of the association to the K+ channel from the for the K+ channel in which a domain as in the is for J. M. J. PubMed Scopus Google Scholar). a domain is not found in the long N-terminal sequence of KvLQT1 isoform 1. is that KvLQT1 the of isoform 1 and truncated isoform 2 to the of and of three of and three isoform 2 Nature. PubMed Scopus Google Scholar) can be used to the of channels expected for each of channel by the the ratio of the cDNA injected protein the of current is on the amount of injected isoform 1 and isoform 2 as or and of at least dominant negative channel to the current be and at isoform 2 ratios of and These with the obtained in the of IsK but not in in the of the dominant negative effects of isoform 2 were pronounced in and also with the Thus, results the the of an isoform 1 for an isoform 2 is the of an isoform 1 for isoform 1 the of isoform 1 for isoform 2 is in the of the IsK and of at least isoform 2 channel These have important physiological the of isoform 2 expression in a channel on the of the IsK In the of the current by KvLQT1 isoform 1 expression that by of isoform 1 plus IsK. findings for and cells as as (4Barhanin J. Lesage F. Guillemare E. Fink M. Lazdunski M. Romey G. Nature. 1996; 384: 78-80Crossref PubMed Scopus (1401) Google Scholar, 5Sanguinetti M.C. Curran M.E. Spector P.S. Zou A. Shen J. Atkinson D. Keating M.T. Nature. 1996; 384: 80-83Crossref PubMed Scopus (1524) Google Scholar, G. C. I. Guillemare E. Barhanin J. Lazdunski M. J. 1997; PubMed Scopus Google Scholar) showed that the channel regulator not only with but also markedly in for with in which KvLQT1 current is F. PubMed Scopus Google Scholar). were performed at whereas in a physiological was we used cDNA whereas classical gene In the heart we observed that KvLQT1 expression is to isoform 2, and is to isoform 1. to the isoform 2 cDNA ratio used in COS-7 expression In the of ratio only of the current in the of isoform 2. in the of 5 IsK of the ratio of the current in the of isoform 2. Our findings that the characteristics of K+ current available for cardiac repolarization on the expression of the three different isoform 1, isoform 2, and IsK. In the of isoform 2 expression the KvLQT1 Fig. 6 a of the of the component of the cardiac delayed rectifier K+ current M.C. J. PubMed Scopus Google Scholar). the dominant negative effects of isoform 2 were in the of IsK. to the inner ear observed in IsK P. J. Lesage F. Lazdunski M. Barhanin J. 1996; 17: PubMed Scopus Google Scholar), isoform 2 expression not in the inner ear during or Mutations in the three are responsible for the inherited long QT to responsible for the most frequent M. Schwartz P.J. Towbin J. Vincent G.M. 1996; 94: PubMed Scopus Google a K+ channel gene at and responsible for the M.E. Splawski I. Timothy K.W. Vincent G.M. Keating M.T. PubMed Scopus Google and a channel gene at responsible for the Q. J. Splawski I. Atkinson D. Moss A.J. Towbin J.A. Keating M.T. PubMed Scopus Google Scholar). locus identified by at F. Peltier S. P. E. P. G. J. Genet. Google Scholar). The of the mutations responsible for the KvLQT1 and the Q. Curran M.E. Splawski I. Burn T.C. Millholland J.M. VanRaay T.J. Shen J. Timothy K.W. Vincent G.M. De Jager T. Schwartz P.J. Towbin J.A. Moss A.J. Atkinson D.L. Landes G.M. Connors T.D. Keating M.T. Nat. Genet. 1996; 12: 17-23Crossref PubMed Scopus (1504) Google N. Tesson F. Denjoy I. Leibovici M. Donger C. Barhanin J. Fauré S. Gary F. Coumel P. Petit C. Schwartz K. Guicheney P. Nat. Genet. 1997; 15: 186-189Crossref PubMed Scopus (752) Google Scholar) and supposedly both isoform 1 and isoform 2. In the heart of a the delayed rectifier K+ current available for repolarization from the association channel protein composed of the isoform 1, isoform 1, isoform 2, isoform 2, and IsK that the effects of KvLQT1 mutations on isoform 2 negative dominance also to be a isoform 2 could or dominant negative on isoform 1. the K+ current to KvLQT1 isoform 1 expression from the dominant negative isoform 2 be on the effects of a familial on isoform 2, the of the delayed rectifier K+ current available for cardiac repolarization the in are the of familial mutations on isoform 2 negative et al. M. J. J. 1997; PubMed Scopus Google Scholar) that KvLQT1 isoform 2 exerts strong dominant negative effects on current in but not the current by expression of or We and for with and plasmid
21
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Mark Curran, Igor Splawski, Katherine W. Timothy et al. · Cell · 1995 · 2.3K citations · Full text
Coassembly of KVLQT1 and minK (IsK) proteins to form cardiac IKS potassium channel
Michael C. Sanguinetti, Mark Curran, Anruo Zou et al. · Nature · 1996 · 1.8K citations
Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias
Q. Wang, Mark Curran, Igor Splawski et al. · Nature Genetics · 1996 · 1.8K citations